Streetbeat News

Products Services

KURA

Kura Oncology has received FDA clearance for its IND application for Ziftomenib to treat advanced GIST. Preclinical data suggest that combining Ziftomenib with Imatinib could resensitize patients and induce durable responses. A Phase 1 study is set to begin in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:38 am

BMWYY

BMW is recalling over 105,000 vehicles in the U.S. due to fire risks from an overheating starter motor. The recall affects several 2019-2021 models, including the X7, X6, X5, and 8 Series Convertible. BMW will update the vehicle software to prevent electrical overload and mitigate fire risks.

Portfolio Pulse from Anan Ashraf

August 08, 2024 | 11:34 am

NOTE

FiscalNote and Empowered Systems have announced a strategic partnership to integrate AI-powered solutions into the Connected Risk Platform. This collaboration aims to enhance third-party risk management with tools like FiscalNote Risk Connector, Copilot for Global Intelligence, and Dragonfly.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:23 am

ALDX

Aldeyra Therapeutics shares are trading higher after the company achieved the primary endpoint in its Phase 3 trial for Reproxalap ophthalmic solution in treating dry eye disease. The company anticipates resubmitting its NDA in 2024.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:20 am

APLS

Apellis Pharmaceuticals and Sobi announced positive Phase 3 VALIANT study results for Pegcetacoplan in treating rare kidney diseases, achieving a 68% reduction in proteinuria. The results were consistent across all subgroups, and data submission is planned for the US and EU. Apellis will host a conference call at 8:00 AM ET.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:20 am

OPTN

Optinose has revised its FY24 net revenue guidance for XHANCE, narrowing the range from $85M-$95M to $85M-$90M. Additionally, the company has increased its expected average net revenue per prescription to at least $250.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:17 am

AMZN

VERI

Veritone has signed a three-year strategic collaboration agreement with Amazon Web Services (AWS) to drive AI and cloud innovation across various sectors including media, entertainment, sports, talent acquisition, and public sectors.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:17 am

ALDX

Aldeyra Therapeutics announced that its Phase 3 trial for Reproxalap Ophthalmic Solution in treating dry eye disease achieved its primary endpoint, showing statistically superior results for ocular discomfort. The company plans to resubmit its NDA in 2024.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:15 am

ORGN

Origin Materials and Reed City Group have announced a partnership to mass produce PET caps and closures in North America. The first production line is set to launch in Q4 2024, aiming to enhance recycling circularity and packaging efficiency.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 11:13 am

ZTEK

Zentek Ltd. (NASDAQ:ZTEK) announced the start of a three-year, $441,000 project in collaboration with University of Toronto professors, funded by an NSERC Mission Alliance Grant. The project focuses on sustainable materials and bioproducts.

Portfolio Pulse from charles@benzinga.com

August 08, 2024 | 11:10 am